Camber started the year off strongly with the addition of 9 new generic products in […]
Camber Launches 9 New Generics in Q1 2026
Currently browsing: News
Camber Attends DCAT Week Alongside Parent Company Hetero
Pictured from left to right: KrishnaMohan Puchakayala, David Smith, Scott Hettenhausen, Susan Ryan, Stuart Messinger, […]
This Month: 4 New Generics from Camber
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launches of Plerixafor Injection, […]
8 Reasons Camber Is a Valued Partner
In an increasingly competitive generics landscape, buyers need partners they can trust for quality, reliability, […]
Camber Launches Pomalidomide Capsules
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Pomalidomide […]
Sodium Oxybate Added to Portfolio
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Sodium […]
Camber Launches Voriconazole for Oral Suspension
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Voriconazole […]
Camber Launches Spironolactone Tablets
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Spironolactone Tablets [spir-ON-oh-LAK-tone]. Spironolactone […]
2025: A Year of Results. 2026: A Year of Opportunity
As we enter 2026, we take a moment to reflect on the significant achievements of […]
Camber Specialty Attends ASHP Midyear 2025
Our Specialty Team recently attended the ASHP 2025 Midyear Clinical Meeting and Exhibition, marking a […]